SCHEMBL13615713

SCHEMBL13615713

Cc1ccc(N(c2ccc(C(C)(C)C)cc2)c2ccc3c(-c4ccc(N(c5ccccc5)c5ccc6ccccc6c5)cc4)c4cc(N(c5ccc(C)cc5)c5ccc(C(C)(C)C)cc5)ccc4c(-c4ccc(N(c5ccccc5)c5ccc6ccccc6c5)cc4)c3c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.36
HTT P42858 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
TSHR P16473 2/20 0.35
GPR84 Q9NQS5 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
ALDH1A1 P00352 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TP53 P04637 1/20 0.33
CYP2A6 P11509 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CTRC Q99895 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
RAB9A P51151 1/20 0.32
PTGES O14684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13333465 0.95 GPR84 (0.37) NPSR1GPR84SMN1; SMN2ALDH1A1CYP3A4
SCHEMBL13333731 0.94 GPR84 (0.36) NPSR1GPR84SMN1; SMN2ALDH1A1CYP3A4
SCHEMBL13333499 0.93 GPR84 (0.36) NPSR1GPR84SMN1; SMN2ALDH1A1CYP3A4
SCHEMBL13615656 0.93 TSHR (0.41) NPSR1L3MBTL1TSHRGPR84SMN1; SMN2
SCHEMBL15762757 0.92 L3MBTL1 (0.42) NPSR1HTTL3MBTL1TSHRGPR84
SCHEMBL13333462 0.92 L3MBTL1 (0.42) NPSR1HTTL3MBTL1TSHRGPR84
SCHEMBL15002728 0.90 GPR84 (0.37) NPSR1GPR84SMN1; SMN2ALDH1A1CYP3A4
SCHEMBL12770700 0.90 GPR84 (0.37) NPSR1GPR84SMN1; SMN2ALDH1A1CYP3A4
SCHEMBL14099657 0.90 L3MBTL1 (0.41) NPSR1HTTL3MBTL1TSHRGPR84
SCHEMBL14099733 0.90 L3MBTL1 (0.41) NPSR1HTTL3MBTL1TSHRGPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090273277-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-11-05 US disclosed
US-20090273277-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-11-05 US disclosed
EP-2103666-A2 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-09-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090273277-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, ORMDL3, CHRM2 NPSR1 2689/4885HTT 2440/4885L3MBTL1 283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.